PECA Labs, Inc., founded in 2012 as a spin-off from Carnegie Mellon University and the University of Pittsburgh, specializes in developing advanced medical devices for pediatric cardiac surgeons. Operating in the pediatric and cardiovascular surgical device market, PECA Labs focuses on creating innovative solutions such as the exGraft and MASA Valve, which are designed to improve surgical outcomes for children with heart conditions. The company serves pediatric cardiac surgeons and healthcare institutions, providing them with cutting-edge tools to enhance the quality of care. PECA Labs generates revenue through the sale of its proprietary medical devices, leveraging its strong research and development capabilities to maintain a competitive edge in the market.

Keywords: pediatric cardiac surgery, medical devices, exGraft, MASA Valve, healthcare innovation, surgical outcomes, pediatric healthcare, cardiovascular devices, Carnegie Mellon spin-off, University of Pittsburgh spin-off.